Global Medtech Guidance Tracker: September 2017
Executive Summary
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight new guidance documents were posted to the tracker.
You may also be interested in...
MDUFA IV Makeover For US FDA Guidances
The US agency detailed new review performance goals and user-fee policies to mark the start of a new fiscal year and five-year user-fee program.
UK MHRA Ensures There Is ‘No Avoiding' Usability Engineering
Changes the UK regulator has made to its guideline on human factors and usability engineering make the document more useful and realistic, and bring it in line with international standards, says a UK-based consultant.
Sponsors Should Consider Representative Race, Age In Trial Design, US FDA Emphasizes
A final guidance document from the agency outlines how device sponsors should approach racial, ethnic and age diversity in trial enrollment and data analysis.